Systech International Adds Distinguished Members to its Board
News Feb 12, 2013
Robert DeJean, President and CEO, Systech International said: “We are delighted to welcome new members to our Board, John Bailye and Michael Fawkes, who bring a vast amount of industry experience and business acumen upon which Systech will draw as we continue to grow.”
John Bailye is a globally accomplished entrepreneur with a resume that runs the gamut from start-ups to proven operational management and strategic leadership in mid to large sized companies. John’s successes reflect a passion for focusing on his customers, both as a source of product direction and, as the ultimate arbiter of his companies’ success.
In a career covering strategic consulting services; leading edge global technology development and deployment and; of late, specialty pharmaceuticals, he has consistently demonstrated his ability to build great management teams and deliver outstanding returns to shareholders. In John’s penultimate role, he guided, developed and grew Dendrite International from a two-person startup company to a complex global business entity over a period of 20 years. Dendrite had $750 million in market capitalized value, over $450 million in annual sales with high profitability, and more than 3000 employees in over 25 countries.
John Bailye said: “I am honored to join Systech’s Board of Directors. As a market leader with innovative technology in a rapidly growing market and new senior management additions, Systech is poised for significant growth. The company is thriving and I’m eager to help shape the organizational direction over the coming months and years.”
Michael Fawkes brings more than 30 years of experience to the Systech Board. Currently he serves as an Independent Director for Saba Software, a NASDAQ listed company, as well as several private technology companies.
From February 2008 through January 2012, Michael served as an Operating Partner with Vantage Point Capital Partners, a leading global investor in energy innovation and efficiency, information technology and healthcare.
Prior to joining Vantage Point Capital Partners, Michael spent 29 years at Hewlett-Packard Company, a leading global provider of products, technologies, software, solutions and services to individuals and businesses, serving in various executive roles in operations and finance, including Senior Vice President of Operations for HP’s Imaging and Printing business. Prior to joining HP, Michael was a CPA with Arthur Andersen. Michael holds a B.B.A. and a M.A. in Finance from the University of Iowa.
Michael Fawkes said: “Systech is positioned very well to make a critical contribution to patient safety as it helps its customers combat counterfeiting in the Pharmaceutical market. Additionally, Systech has a tremendous opportunity to advance its offering to other markets. I am thrilled to have the opportunity to work with Systech as its scales for the future.”
Computer bits are binary, with a value of 0 or 1. By contrast, neurons in the brain can have all kinds of different internal states, depending on the input that they received. This allows the brain to process information in a more energy-efficient manner than a computer. A new study hopes to bring the two closer together.
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
5th International Congress on Epigenetics & Chromatin
Aug 22 - Aug 23, 2019